Medivizor

Title of notification

Here comes the notification
X
 
icon
prostate cancer | Research | 11 pages | source: Urology | Added Jul 31, 2019

Quality of life in prostate cancer survivors

The authors evaluated the impact of prostate cancer on the quality of life of prostate cancer survivors.  

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: The New England Journal of Medicine | Added Jul 29, 2019

Evaluating enzalutamide to treat metastatic prostate cancer

This study aimed to examine the effectiveness and safety of enzalutamide (Xtandi) in metastatic prostate cancer. This study found that enzalutamide was associated with longer progression-free and overall survival compared to standard of care.

icon
prostate cancer | Research | 10 pages | source: Cancer | Added Jul 22, 2019

Depression in prostate cancer survivors

This study aimed to investigate depression in prostate cancer patients. This study found that depression is a major challenge for prostate cancer survivors.

icon
prostate cancer | Research | 10 pages | source: The journal of sexual medicine | Added Jul 14, 2019

Male urethral "Mini-Sling" in treating stress urinary incontinence and climacturia after prostate cancer treatment

This study aimed to investigate the use of the 'mini-sling' surgery during placement of penile prosthesis for the treatment of urinary incontinence and climacturia (urine leaking during sexual intercourse) in men with erectile dysfunction after prostate cancer treatment. This study found that this procedure is promising for these patients.

icon
prostate cancer | Research | 10 pages | source: BJU international | Added Jun 30, 2019

What is the risk for bladder and rectal cancer in patients previously treated for localized prostate cancer?

This study investigated the rate of bladder cancer (BC) and rectal cancer (RC) after localized prostate cancer (PC) treatment.

They found that brachytherapy (BT) increased the risk of BC and RC in these patients. 

icon
prostate cancer | Research | 10 pages | source: European Urology | Added Jun 11, 2019

Nerve grafting to restore erectile function after radical prostatectomy

This article investigated the safety and efficacy of end-to-side nerve grafting surgery (NGS) in patients with erectile dysfunction (ED) after prostate surgery. 

The authors concluded that NGS was a safe and effective treatment option for these patients.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: International journal of urology: official journal of the Japanese Urological Association | Added Jun 02, 2019

Long term outcomes of docetaxel-based chemotherapy with dexamethasone for advanced prostate cancer

This article investigated the safety and effectiveness of docetaxel (Taxotere)-based chemotherapy in combination with dexamethasone (Decadron) for the treatment of castration-resistant prostate cancer (CRPC). The authors concluded that this treatment combination is a safe and effective treatment option for advanced prostate cancer.  

icon
icon
prostate cancer | Research | Treatment | 8 pages | source: Annals of oncology | Added May 26, 2019

High precision radiation therapy; is it warranted in high-risk prostate cancer?

This study aimed to evaluate the benefit associated with use of intensity-modulated radiation therapy (IMRT), a form of high precision radiation therapy.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added May 22, 2019

Abiraterone acetate plus prednisone: an evaluation of the long-term effectiveness in prostate cancer treated with hormonal therapy.

This study investigated if abiraterone acetate (Zytiga) and prednisone (Deltasone) added to androgen deprivation therapy (ADT) improve survival in patients with advanced prostate cancer. They found that this combination was effective at improving survival in these patients.

icon
icon
prostate cancer | Research | Treatment | 9 pages | source: European Urology | Added May 17, 2019

The prevention of bone loss in prostate cancer patients undergoing ADT

This study evaluated the use of alendronate (Fosamax) for the prevention of bone loss in men undergoing androgen deprivation therapy (ADT) for localized prostate cancer.

View

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?